Venetoclax to Augment Epigenetic Modification and Chemotherapy

Conditions:   Acute Myeloid Leukemia, in Relapse;   Acute Myeloid Leukemia Refractory Interventions:   Drug: Venetoclax;   Drug: Azacitadine;   Drug: Vorinostat;   Drug: Cytarabine;   Drug: Fludarabine;   Drug: Filgrastim Sponsor:   Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials